Journal article: efficacy of pretreatment with the free radical scavenger, edaravone, for prevention of cerebral hyperperfusion after carotid artery stenting: a single-center randomized controlled trial.Journal: interdisciplinary neurosurgery: advanced techniques and case year: 2021 ref: doi.Org/10.1016/j.Inat.2021.101092.Patient age: average age.Sex: majority gender.Event date: date of publication.
|
A journal article titled - efficacy of pretreatment with the free radical scavenger, edaravone, for prevention of cerebral hyperperfusion after carotid artery stenting: a single-center randomized controlled trial - was submitted for review.This is a randomized controlled trial (rct) of 51 patients which aimed to evaluate whether pre-treatment with a free radical scavenger, edaravone, can prevent cerebral hyperperfusion (chp) after carotid artery stenting (cas).The medtronic guardwire embolic protection device was among the devices used during the procedures for distal protection.One patient experienced an embolic complication during cas and could not be included in the trial.Perioperative complications occurred in 3 patients: 2 had ischemic stroke or transient ischemic attack, and one patient had retroperitoneal hemorrhage caused by femoral artery puncture site bleeding.Of the 51 patients, 3 had chp, including one with transient postprocedural hypotension.The trial was stopped ahead of schedule due to poor recruitment.
|